Journal of Participatory Medicine
Co-production in research and healthcare, technology for patient empowerment and fostering partnership with clinicians.
Editor-in-Chief:
Amy Price, DPhil, Senior Research Scientist, The Dartmouth Institute for Health Policy and Clinical Practice Geisel School of Medicine, Dartmouth College, USA
CiteScore 3.1
Recent Articles

Humanity stands at the threshold of a new era in biological understanding, disease treatment, and overall wellness. The convergence of evolving patient and caregiver (consumer) behaviors, increased data collection, advancements in health technology and standards, federal policies, and the rise of artificial intelligence (AI) is driving one of the most significant transformations in human history. To achieve transformative healthcare insights, AI must have access to comprehensive longitudinal health records (LHRs) that span clinical, genomic, non-clinical, wearable and patient generated data. Despite the extensive use of electronic medical records (EMR) and widespread interoperability efforts, current healthcare organizations, EMR vendors, and public agencies are not incentivized to develop and maintain complete LHRs. This paper explores the new paradigm of consumers as the common provenance and singular custodian of LHRs. With fully aligned intentions and ample time to dedicate to optimizing their health outcomes, patients and caregivers must assume the sole responsibility to manage or delegate aggregation of complete, accurate, and real-time LHRs. Significant gaps persist in empowering consumers to act as primary custodians of their health data and to aggregate their complete LHRs, a foundational requirement for the effective application of AI. Rare disease communities – leaders in participatory care – offer a compelling model for demonstrating how consumer-driven data aggregation can be achieved and underscore the need for improved policy frameworks and technological tools. The convergence of AI and LHRs promises to transform medicine by enhancing clinical decision-making, accelerating accurate diagnoses, and dramatically advancing our ability to understand and treat disease at an unprecedented pace.

Most definitions of therapeutic empathy are based on practitioners’ perspectives and few account for patients’ views. We therefore do not understand what therapeutic empathy means to patients. Given that therapeutic empathy involves a relationship between patients and practitioners, the under-representation of the patient voice threatens to undermine the validity of therapeutic empathy definitions and subsequently, how the concept is measured, taught, and practiced.


Artificial intelligence (AI) is reshaping medical imaging with the promise of improved diagnostic accuracy and efficiency. Yet, its ethical and effective adoption depends not only on technical excellence but also on aligning implementation with patient perspectives. This commentary synthesizes emerging research on how patients perceive AI in radiology, expressing cautious optimism, a desire for transparency, and a strong preference for human oversight. Patients consistently view AI as a supportive tool rather than a replacement for clinicians. We argue that centering patient voices is essential to sustaining trust, preserving the human connection in care, and ensuring that AI serves as a truly patient-centered innovation. The path forward requires participatory approaches, ethical safeguards, and transparent communication to ensure that AI enhances, rather than diminishes, the values patients hold most dear.

Artificial intelligence (AI) Is rapidly transforming healthcare, offering potential benefits in diagnosis, treatment, and workflow efficiency. However, limited research explores patient perspectives on AI, especially in its role in diagnosis and communication. This study examines patient perceptions of various AI applications, focusing on the diagnostic process and communication.

Major Depressive Disorders (MDD) significantly impacts individuals’ lives, with varied treatment responses necessitating personalized approaches. Shared decision-making (SDM) enhances patient-centred care by involving patients in treatment choices. To date, instruments facilitating SDM in depression treatment are limited, particularly those that incorporate personalized information alongside general patient data and in co-creation with patients.


Patient portals demonstrate significant potential for improving healthcare engagement but face critical adoption challenges. Disparities persist across different demographic groups, creating a digital divide in healthcare access. Targeted training strategies, particularly personalized and one-on-one approaches, show promise in increasing portal utilization. Innovative solutions, like community health workers specializing in digital navigation, offer a potential pathway to reduce enrollment barriers. The key challenge remains developing a scalable, cost-effective training model.

Patient engagement in research represents an evolution in how new knowledge is being created. Individuals and teams seeking to conduct research in this way want to learn how to best approach this work. Specialized training is required to ensure that these individuals and groups have the knowledge and skills to engage with and accomplish these goals. We developed an on-line training program, called Patient-Oriented Research Training & Learning - Primary Health Care (PORTL-PHC), to address this need.

This paper will view the rise of the e-patient, who is “equipped, enabled, empowered and engaged” through the lens of the evolution of successive digital technology innovations, each building on its predecessors, creating new tools for patient empowerment. We begin with the dawn of the Web and the proliferation of health websites and discuss the use of digital communication tools. We then discuss the adoption of electronic health records which enabled the rise of patient portals. This digitization of health data, along with the rapid adoption of mobile internet access and the proliferation of health-related smartphone apps, in turn, provided a platform for patients to co-produce healthcare by contributing their own health data to their self-care and healthcare. The exchange of health information between patients and providers has also been facilitated by telehealth/telemedicine technology which enables direct care delivery. The use of social networks in health, in use since the early days of the Web, has expanded since COVID, when public health authorities worldwide, as well as patients, sought the use of social media channels to get connected and share information. Most recently, artificial intelligence and large language models have emerged with yet untapped potential to provide patients with the information that could improve their understanding of their conditions and treatment options. We conclude that innovations in digital health technology have symbiotically evolved with the ascendance of the e-patient, enabling improved communication, collaboration, and coordination between patients and clinicians and forging a healthcare system that is safer and more responsive to patient needs.

Chronic wounds affect 1-2% of the global population, and pose significant health and quality-of-life challenges for patients and caregivers. Advances in artificial intelligence (AI) and computer vision (CV) technologies present new opportunities for enhancing wound care, particularly through remote monitoring and patient engagement. A Digital Wound Care Solution (DWCS) that facilitates wound tracking using AI/CV was redesigned as a patient-facing mobile application to empower patients and caregivers to actively participate in wound monitoring and management.

Clinical trial registries were designed to help patients search for potentially suitable clinical trials. When our family faced another serious cancer diagnosis, we searched multiple international clinical trial registries. Despite increasing evidence that trials designed WITH patients can be better for trial participants (eg, more relevant outcome measures, fewer burdens), it is currently impossible to search registries for these specific types of trials. In this Patient Perspective article, we make the first ‘call to action’ for clinical trial registries to include (1) a filter that allows for efficient searching for clinical trials designed with patients and (2) structured information, in plain language, on how patients were involved. We propose how these two innovations could help reduce barriers to clinical trial participation. We also highlight how new regulatory and ethical guidelines are encouraging patient involvement in trial design and we identify the benefits to many of doing so. Given the pressing need to improve clinical trial participation, we respectively call on the clinical trial community to respond to our ‘call to action’ and consider our proposed action plan. Ideally, when patients want to search for clinical trials designed with patients for patients, we should be able to find them. A plain language summary for this publication is available (Supplementary File 1).